Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

J&J in the Hunt for China M&A

publication date: Sep 17, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Johnson & Johnson is using “external innovation” in China as a low-cost, highly inventive path to discover new drugs. "We have to seek the best science and technology,” said Lily Lee, PhD, vice-president and head of JNJ Pharmaceutical R&D Asia, at a recent Shanghai biopharma meeting. "We are especially interested in oncology, infectious diseases and metabolic areas, so M&As in these areas will be high on our radar screen," she continued. More details....

Stock Symbol: (NYSE: JNJ)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners